The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study-Reference-Cited by-同舟云学术

The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study

Published:2018-04-19 Issue:6 Volume:67 Page:2244-2253
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Li Darrick K.¹²,Ren Yanjie³,Fierer Daniel S.⁴,Rutledge Stephanie¹,Shaikh Obaid S.³,Lo Re Vincent⁵,Simon Tracey¹²^ORCID,Abou-Samra Abdul-Badi⁶⁷,Chung Raymond T.¹²,Butt Adeel A.³⁶⁷

Affiliation:

1. Department of Medicine; Massachusetts General Hospital; Boston MA

2. Liver Center, Division of Gastroenterology, Department of Medicine; Massachusetts General Hospital; Boston MA

3. VA Pittsburgh Healthcare System; Pittsburgh PA

4. Division of Infectious Diseases; Icahn School of Medicine at Mount Sinai; New York NY

5. Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, Perelman School of Medicine; University of Pennsylvania; Philadelphia PA

6. Hamad Medical Corporation; Doha Qatar

7. Weill Cornell Medical College; Doha, Qatar and New York NY

Funder

NIH

MGH

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29707/fullpdf

Reference28 articles.